1. Home
  2. RNTX vs ORIO Comparison

RNTX vs ORIO Comparison

Compare RNTX & ORIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RNTX

Rein Therapeutics Inc.

HOLD

Current Price

$1.30

Market Cap

30.0M

Sector

Health Care

ML Signal

HOLD

ORIO

Orion Digital Corp. Common Shares

N/A

Current Price

$1.02

Market Cap

27.1M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
RNTX
ORIO
Founded
2001
N/A
Country
United States
Canada
Employees
11
178
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
30.0M
27.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
RNTX
ORIO
Price
$1.30
$1.02
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$10.00
N/A
AVG Volume (30 Days)
94.8K
55.4K
Earning Date
05-14-2026
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$78.15
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$4.93
Revenue Growth
N/A
N/A
52 Week Low
$1.02
$0.95
52 Week High
$2.22
$1.40

Technical Indicators

Market Signals
Indicator
RNTX
ORIO
Relative Strength Index (RSI) 54.09 34.91
Support Level $1.06 N/A
Resistance Level $1.30 $1.25
Average True Range (ATR) 0.12 0.06
MACD -0.00 -0.01
Stochastic Oscillator 51.43 9.52

Price Performance

Historical Comparison
RNTX
ORIO

About RNTX Rein Therapeutics Inc.

Rein Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing therapies in orphan pulmonary and fibrosis indications, including two Phase 2-ready clinical assets. The company's product candidate includes LTI-03: a peptide for which company conducted a Phase 1b dose-ranging, placebo-controlled safety, tolerability, and pharmacodynamic biomarker activity trial in development for the treatment of Idiopathic Pulmonary Fibrosis; LTI-01: proenzyme that completed a Phase 2a dose-ranging, placebo-controlled trial and a Phase 1b safety, tolerability and proof of mechanism trial in loculated pleural effusion, or LPE, patients, an indication that has no approved drug treatment; and LTI-05 and others.

About ORIO Orion Digital Corp. Common Shares

Orion Digital Corp is a digital finance company operating across wealth, payments, and digital assets. Through its Investing wealth platform, Carta World-wide payments infrastructure, and long-duration Bitcoin treasury plan - combined with a disciplined, multi-engine compounding model. Orion Digital is focused on compounding value through execution, scale, and capital discipline.

Share on Social Networks: